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Abstract
Background: The prevalence and incidence of asthma are believed to be increasing but research on the true
incidence, prevalence and mortality from asthma has met methodological obstacles since it has been difficult to
define and diagnose asthma in epidemiological terms. New and widely accepted diagnostic criteria for asthma
present opportunities for progress in this field. Studies conducted in Portugal have estimated the disease
prevalence between 3% and 15%. Available epidemiological data present a significant variability due to
methodological obstacles.
Aim: To estimate the true prevalence of asthma by gender and age groups in the population of the area covered
by one urban Health Centre in Portugal.
Method: An observational study was conducted between February and July 2009 at the Horizonte Family Health
Unit in Matosinhos, Portugal. A random sample of 590 patients, stratified by age and gender was obtained from
the practice database of registered patients. Data was collected using a patient questionnaire based on respiratory
symptoms and the physician’s best knowledge of the patient’s asthma status. The prevalence of asthma was
calculated by age and gender.
Results: Data were obtained from 576 patients (97.6% response rate). The mean age for patients with asthma was
27.0 years (95% CI: 20.95 to 33.16). This was lower than the mean age for non-asthmatics but the difference was
not statistically significant. Asthma was diagnosed in 59 persons giving a prevalence of 10.24% (95% CI: 8.16 to
12.32). There was no statistically significant difference in the prevalence of asthma by gender.
Conclusion: The prevalence of asthma found in the present study was higher than that found in some studies,
though lower than that found in other studies. Further studies in other regions of Portugal are required to confirm
these findings.
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Background
Asthma is a common chronic disease world-wide with a
high prevalence in all age groups, mostly in children and
young people yet there is wide variation in the prevalence
of the condition between and within countries [1-8].
Asthma prevalence and incidence are believed to be
increasing [9-11], though this view is controversial
[2,12,13].
Asthma is also an important reason for hospital
admission [14,15] and causes considerable limitations on
the physical, emotional, social, and professional lives of
both patients and their families, interfering with normal
activity and quality of life [16,17].
Available epidemiological data on the incidence, preva-
l e n c ea n dm o r t a l i t yf r o ma s t h m ap r e s e n ts i g n i f i c a n t
variability as research has met with methodological
obstacles since it is difficult to define and diagnose
asthma in epidemiological terms [2,18,19]. Some studies
used non-standardized questionnaires while other
included patients after a pulmonary function assessment
or proof of bronchial responsiveness. Because of the dif-
ferences in methodology, considerable differences of
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widely accepted diagnostic criteria for asthma present
opportunities for progress in this field.
T h eG l o b a lI n i t i a t i v ef o rA s t h m a( G I N A )l i s t ss o m e
actions required to reduce the burden of asthma. One
task is to recognise asthma as an important cause of
morbidity, economic cost, and mortality worldwide and
to measure and monitor the prevalence of asthma, and
the morbidity and mortality due to asthma throughout
the world [2].
T h eP o r t u g u e s eA s t h m aC o n t r o lP r o g r a mw a sd e v e l -
oped in 2000 [20] and, in line with the GINA proposal,
recommended regular studies on epidemiological and
clinical follow up of asthma. The Portuguese Guidelines
on the diagnostic and control of asthma, based on the
existing GINA Guidelines, were also published in 2000
[21] and were updated in 2007 [22] after the 2006
changes of the GINA Report.
Several studies conducted in Portugal have estimated
the disease prevalence as ranging from 3.3% to 15%
[ 2 3 - 3 2 ] .M o s to ft h eP o r t u g u e s ed a t aa v a i l a b l ew e r e
obtained before 2006, covered limited age groups or were
obtained using methodologies with questionable accuracy
of the prevalence rates.
This study was conducted to determine the prevalence
of asthma by gender and stratified age groups in the
Horizonte Family Health Unit in Matosinhos Portugal
in 2009 to increase our knowledge of the epidemiology
of asthma.
Method
Study population
Matosinhos, Portugal is a suburb of the city of Porto with
a population of 169,261 inhabitants in 2008. The age and
gender distribution of Matosinhos is similar to that of
the total Portuguese population [33]. The population of
the Horizonte Family Health Unit is similar in age and
gender distribution in turn to the population of Portugal
(Additional file 1, Appendix 1 - Comparison of the prac-
tice population with the Portuguese Population).
The Horizonte Family Health Unit is a group practice
formed by eight family physicians working together for
more than ten years with a stable registered population.
The change in the population of registered patients in the
practice between 2008 and 2009 was an increase of 1.88%.
There is a good accessibility to healthcare. Most patients
can be seen by any of the partners in case of their personal
doctor is absent with continuity of the electronic medical
record. The unit is a training practice for basic medical
education and postgraduate family medicine residency
training programmes. These characteristics of the practice
provide a unique opportunity for epidemiological studies.
An observational study was conducted between February
and July 2009 at the Horizonte Family Health Unit.
A stratified random sample by age and gender was
obtained from the practice general database of 13,568
registered patients.
Justification of age strata
The study population was divided into four age strata: 0
to 7 years, 8 to 19 years, 20 to 64 years and over 65 years.
The youngest age group of birth to 7 years was selected
to represent the age when asthma tends to be most pre-
valent and hospital admission rates are higher. The sec-
ond age group of 8 to 19 years was chosen to study the
period when mortality from asthma has been found to be
highest [34]. Adults aged 20 to 64 and the elderly aged 65
and over were studied separately because diagnostic pro-
blems regarding asthma are common in the elderly.
Sampling procedures
Based on the available published literature a prevalence of
asthma was predicted in this population for the four age
strata. In the 0 to 7 year age group a prevalence of 11%
was predicted, for 8-19 years 11.8%, for 20 to 64 years 5%,
and for over 65 years 5%. Using the method of Lehr [35], a
sample size calculation was performed to determine the
true prevalence of asthma in each age group plus or minus
2% with 95% confidence. In the 0 to 7 year age group 150
patients would be required, for 8-19 years 160 patients, for
20 to 64 years 140 patients, and for over 65 years 140
patients. Thus a sample of 590 patients would be required
in this population.
The required number of patients was selected from
each age group using the patient register in the practice
and a random number generator.
Data collection
Data were collected using two questionnaires: a physician’s
questionnaire (Additional file 2, Appendix 2 - Physician
Questionnaire) and a patient questionnaire (Additional file
3, Appendix 3 - Patient Questionnaire). The physician’s
questionnaire consisted of demographic information
including the age and gender of each of the selected
patients and clinical data on asthma. The first question
was “does this patient have asthma?” If the answer was
positive, the family doctor was required to answer four
sets of questions. The first questions asked about the pre-
sence of wheezing. The second set assessed a past or pre-
sent history of dry cough, recurrent wheeze, dyspnoea/
recurrent difficulty in breathing or recurrent chest tight-
ness. The third set of questions assessed the evidence of
reversibility of airflow obstruction after administration of a
short acting bronchodilator through clinical observation
only, peak flow measurement or spirometry. The fourth
question asked if a diagnosis of asthma had been made by
a secondary care specialist in case the diagnosis had not
been made by the family doctor alone.
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questionnaire [36] and consisted of demographic infor-
mation including age and gender and 13 questions on
asthma. Eight questions where about symptoms and
used the ISAAC core questionnaire for wheezing and
asthma. The first group of questions asked about the
presence of wheezing at present and specifically in the
last 12 months, the number of attacks of wheezing in
the last 12 months, wheezing during or after exercising,
and waking up because of wheezing or dry cough at
night in the last 12 months. Patients were asked if they
ever had asthma or if they had ever been told by a doc-
tor that they had asthma. The second section consisted
on five questions about medication. Questions were
asked on the use of any form of asthma medication in
the last 12 months and covered all the commercial alter-
natives available in Portugal including the colour and
the brand names of both inhalers and tablets. An algo-
rithm of diagnostic steps was used to make the diagno-
sis of asthma based on the responses obtained in the
study questionnaires (Figure 1).
In the first phase of the study, between February and
April 2009, all eight physicians in the health unit were
asked to report on each of the selected patients that
were seen during routine scheduled appointments for
any clinical reason. Each family doctor completed the
physician’s questionnaire. Each patient was invited to
answer a questionnaire based on respiratory symptoms
and signed an informed consent form.
In the second phase, between April and July 2009, all the
patients who had missed an appointment were contacted
by phone and invited for an interview with the researchers,
while the family physician was asked to fill in the doctor’s
questionnaire. Any patient who failed to answer the phone
after three attempts or refused to participate was replaced
by another patient with similar age and gender character-
istics (next random number in the same age group).
Patients who did not have any appointment during the
first phase were also contacted by phone.
The diagnostic procedures were based on a combination
of the answers given by the patient on respiratory symp-
toms and the physician’s best knowledge of the patient’s
asthma status. If the family doctor answered “no” to the
question “Does this patient have asthma?” and the patient
reported the absence of asthma symptoms, it was consid-
ered that asthma was not present. If the doctor answered
“yes” to the same question and the patient reported symp-
toms of asthma (“probable cases”), the diagnostic algorithm
was used (figure 1) in order to confirm or reject the diag-
nosis. In cases of inconsistency between the information
provided by the family doctor and the patient (“doubtful
cases”), an interview was conducted by the researchers
with an assessment of the patient to validate the diagnosis.
Data analysis
Data were entered on an electronic spreadsheet program
and analyzed using Epi-Info version 3.5.1 software. The
prevalence of asthma was calculated for the total popu-
lation and for specific age groups by dividing the num-
ber of cases found by the size of the population.
Standardized rates were computed using Portuguese
census data for 2005 [33].
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Figure 1 Steps to the diagnosis or exclusion of asthma in the asthma prevalence study
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used in the symptom questionnaire and the diagnostic
algorithm described above for a diagnosis of probable
asthma or doubtful asthma, odds ratios and 95% confi-
dence intervals were calculated using the Epi-Info
TABLES function. This was done to determine which
items in the history were most likely to be associated
with a final diagnosis of asthma.
Ethical approval
Prior to data collection, the study protocol was approved
by the Ethics Committee of the Local Health Authority
in Matosinhos (Unidade Local de Saúde de Matosinhos).
Each patient invited to participate signed an informed
consent form after the aims and methods of the study
were explained. All new cases of asthma or uncontrolled
cases found in the study were referred back to their
family physician for treatment.
Results
From the stratified random sample of 590 patients
selected from the population of the Horizonte Family
Health Unit, data were obtained from 576 patients (for a
response rate of 97.6%, Figure 2). The characteristics of
the study population are given in Table 1.
The mean age of this population was 33.2 years (sd =
28.1 years; 95% CI: 30.9 to 35.5), and 297 (51.6%) of the
patients in the sample were female.
Using the GINA criteria, asthma was diagnosed in 59
persons giving a prevalence of 10.24% (95% CI: 7.76 to
12.72).
A diagnosis of “probable asthma” was initially made in
37 patients (6.4%) and 102 patients were classified as
“doubtful cases”
Following a medical record review and interview of
doubtful cases, 22 were reclassified as asthmatic (for a
total of 59 cases), 514 as healthy and 3 (0.5%) remained
as doubtful cases.
The mean age for patients with asthma was 27.0 years
(sd 23.4, 95% CI: 21.0 to 32.9). For non-asthmatics the
mean age was 33.9 years (sd 28.5, 95% CI: 31.4 to 36.3).
This difference was not statistically significant.
T h em e a na g ef o rm a l ep a t i e n t sw i t ha s t h m aw a s2 2 . 0
years (sd 17.8; 95% CI: 15.5 to 28.5) with a median age
of 18.3 years. For males without asthma the mean age
was 33.4 (sd 27.7; 95% CI: 29 to 36) with a median age
of 19.7 years. This difference was statistically significant
(p < 0.05).
The mean age for female patients with asthma was
34.2 years (sd 28.9; 95% CI: to 41.5) with a median age
of 18.2 years. For females without asthma the mean age
was 34.5 (sd 29.2; 95% CI: 31 to 38) with a median of
19.3 years. This difference was not statistically
significant.
Female patients comprised 51.8% of the asthma
patients. There was no statistically significant difference
Population of
Horizonte Clinic
N=13568
Random Sample
N=590 (4.2%)
Responders
N=576 (97.6%)
Non-Responders
N=14
Probable Non-
Asthma
N=437
Probable Asthma
N=37
New Asthma Cases
N=22
Total Asthma Cases
N=59 (10.2%)
New Non-asthma
cases
N=77
Total Non-asthma
N=514
First look – patient questionnaire
Second look – physician evaluation
Final diagnosis
Possible Cases
N=102
Doubtful
N=3
Figure 2 Flow chart of patient recruitment and evaluation in asthma prevalence study.
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population.
Among young children under the age of 8 years the
prevalence of asthma is higher in males (13%) than in
females (7%) but this difference is not statistically signif-
icant in this population (OR = 2, 95% CI, 0.6 to 6.9).
Among patients over 65 years of age the prevalence is
higher in females (7.3%) than in males (1.7%) but this
difference is not statistically significant (OR = 0.2, 95%
CI = 0.004 to 1.9).
Asthma prevalence by age group in the sample popu-
lation and standardized for the Portuguese population is
given in table 2.
Associations between symptoms and diagnosis
The association between positive symptoms elicited in
the patient questionnaire and a final diagnosis of asthma
was tested by computing the odds ratio (OR) for a posi-
tive reply comparing true cases of asthma with doubtful
cases (Table 3). The following items were found to be
statistically significant: wheezing after exercise (OR 4.2),
waking up from wheezing (OR 3.4), a personal history
of asthma (OR 12), being told by a doctor that the
patient has asthma (OR 14.6), use of a short-acting beta
agonist in last 12 months, (OR 35.6), use of a long-act-
ing beta agonist in last 12 months (OR 7.6), and the use
of an inhaled steroid in last 12 months (OR 25).
Discussion
This study found that the prevalence of asthma in the
population of the area covered by the Horizonte Family
Health Unit in Matosinhos, Portugal was 10.24% using
data collected from a random sample of the registered
population.
In Portugal, the composition of the population of
patients registered on the lists of general practitioners is
very similar to the general population living in the
region. This was described in a recent publication on
the incidence of asthma using general practice popula-
tions [37]. The population described in the general prac-
tice in current study is believed to be representative of
Matosinhos therefore these findings are believed to
represent the prevalence of asthma in this population.
Internal validity
The findings of this study are believed to represent the
true prevalence of asthma in this population. This is due
to use of a stratified random sample drawn from accu-
rate patient lists with a good response rate. In the case
of non-responders, replacements were drawn from a list
of alternates also produced by the random number gen-
erator. The use of accepted diagnostic criteria validated
by additional interview and examination by physicians
in cases of doubt regarding the diagnosis also increases
confidence in the quality of the data. In some age
groups the wide confidence intervals for the prevalence
of asthma is due to the small numbers of cases found. A
similar study in a larger population will resolve this
issue further.
Study questionnaire and diagnostic criteria
The patient questionnaire was based on the Portuguese
version of the ISAAC questionnaire which had been
previously used in Portugal as part of an international
Table 2 Asthma prevalence by age group in the sample population and standardized for the Portuguese population
Age groups Asthma Non-asthma Prevalence % 95% CI Prevalence % Standardized for Portuguese Population
0 to 7 13 123 9.56 5.41 to 13.71 8.6
8 to 19 21 139 13.13 8.74 to 17.52 13.1
20 to 64 18 122 12.86 8.21 to 17.51 12.3
≥ 65 7 133 5.00 1.97 to 8.03 6.3
Total 59 517 10.24 8.16 to 12.32
Total sample 576
(The three “doubtful cases” were included with the non-asthma patients in this table.)
Table 1 Demographic characteristics of study sample by gender, age and diagnosis
Total sample
N = 576
Mean age
Asthma cases
N=5 9
Mean age
Non-asthma
N = 517
Mean age
33.2 years (s.d. 28.1) 27.0 years (s.d. 23.4) 33.9 years (s.d. 28.5)
Males 32.2 years (s.d. 27.1)
N = 279 (48.4%)
22.0 years (s.d. 17.8)
N=2 9
33.4 years (s.d. 27.7)
N = 250
Females 34.2 years (s.d. 28.9)
N = 297 (51.6%)
31.8 years (s.d. 27.2)
N=3 0
34.5 years (s.d.29.2)
N = 267
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about asthma symptoms from the questionnaire.)
The physician questionnaire was constructed using the
guidelines in the GINA 2006 Report [38]. Questions
were asked about the presence of wheezing, past or pre-
sent history of dry cough, recurrent wheeze, dyspnoea/
recurrent difficulty in breathing or recurrent chest tight-
ness and the evidence of reversibility of airflow obstruc-
tion after administration of a short acting
bronchodilator through clinical observation only, peak
flow measurement or spirometry. The same question-
naire was used in a study on the incidence of asthma
and accuracy of diagnosis in the Portuguese sentinel
practice network [37]. The utility of this questionnaire
in these two studies suggests that future study of asthma
prevalence could also use these diagnostic criteria.
Comparison of findings with other published studies
There are many published studies on the prevalence of
asthma but the absence of a precise and universally
accepted definition of asthma makes reliable comparison
of reported prevalence from different parts of the world
problematic [2].
Portuguese studies
The prevalence of asthma found in the present study for
the general population was considerably higher than
that found in previous studies in Portugal though differ-
ent methodologies and age groups have been used. Care
is required in comparison of these results with findings
from other studies. In the survey published in 1987 by
Nunes et al [24] for patients aged 7 to 17 years observed
regularly using a symptom score and spirometry, a pre-
valence of 3.4% was found. In 1990 Chieira et al [25]
studied 557 twenty year old male conscripts using a
questionnaire and clinical observation and found a pre-
valence of 5.2%. In 1991 Marques [39] studied a random
sample of 2000 inhabitants of the city of Porto aged 20
to 44 years using the ECRHS questionnaire and found a
prevalence of 4.3%. In 1992 Nunes et al [26] published a
report on 55,254 subjects in Algarve, Portugal using a
questionnaire and found a prevalence of 5.5% among
patients attending primary care consultations. In 1994
Alves et al [23] published the results of a survey in the
city of Porto using a postal questionnaire and found a
prevalence of 3.1% for the diagnosis of asthma and
6.45% for asthma symptoms in persons of both genders
aged 18 to 44 years. In 1994 Prata et al [27] studied 927
children 6-12 yrs old in Faial, Azores, and met a preva-
lence of 8.0%. In 1995 Vicente et al [28] studied 17,200
students aged 12-19 yrs living in eight major cities in
Portugal and found a prevalence of 3.2%. In 1996 Mor-
ais Almeida et al [29] used a questionnaire to study a
sample of 1,061 children aged 6-10 yrs in the Madeira
Island, Portugal and met a prevalence of 15%. In 1998
Leiria Pinto P et al [30] studied 1,334 adolescents aged
12-16 yrs living in Lisbon using a questionnaire and
found a prevalence of 11.4%.
The 2005 Portuguese National Health Survey [40]
found an overall asthma prevalence of 5.5%. The
method used for data collection was a home interview
of a stratified representative sample of the Portuguese
population with self-report on the conditions of interest.
In 2005 Branco et al [31] used a telephone interview
with a random sample of 1,211 households in mainland
Portugal and a total of 2,820 subjects of all ages as part
of a survey of chronic conditions. The prevalence of
self-reported asthma was 8.6%. Table 4 displays a com-
parison of asthma prevalence rates for all age groups
and methods in Portuguese surveys.
International studies
The comparison of the Matosinhos survey results with
other international data confirms that they are close to
Table 3 Odds ratios for the association of positive symptoms with a diagnosis of asthma
From the patients’ questionnaire, the following items were positive: Asthma cases (n = 59) Doubtful cases (n = 39) O.R. (95% CI)
Any history of wheezing 57 (96%) 38 (97%)
Wheezing in the last 12 months 40 (67%) 22 (26%)
Wheezing after exercise 19 (32%) 4 (10%) 4.2 (1.2-18.1)
Wake up from wheezing 23 (39%) 6 (15%) 3.4 (1.1-11.7)
Night time dry cough 40 (67%) 20 (51%)
Personal history of asthma 45 (76%) 8 (20%) 12 (4.2-37.9)
Told by a doctor they have asthma 47 (80%) 8 (20%) 14.6 (5-47)
Use of SABA in last 12 months 29 (49%) 1 (3%) 35.6 (5-1358)
Use of LABA in last 12 months 10 (17%) 1 (3%) 7.6 (1.00-345)
Use of Inhaled steroid in last 12 months 24 (40%) 1 (3%) 25 (3.7-1099)
Use of LABA-steroid in last 12 months 4 (7%) 1 (3%)
Use of leukotriene in last 12 months 11 (19%) 0
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Health Survey from 2003, [41] the prevalence of diag-
nosed asthma showed a narrow range across countries.
There was a 10-fold variation in current wheezing
symptom prevalence across countries (2.4% in Vietnam
and 24.3% in Brazil). The majority of estimates fell
within a fourfold range of prevalence, with Vietnam the
lowest at 1.8% and Australia the highest at 32.8%.
The 2003 Global Burden of Asthma document [3]
published on behalf of the GINA project compares the
mean prevalence of clinical asthma in different regions.
It ranges from 2.1% in Central North Asia (China/Tai-
wan/Mongolia) to 16.1% in the United Kingdom and
Republic of Ireland. Prevalences are higher in North
America, Oceania and West and Eastern Europe than in
Asia or Africa. Southern Africa (8.1%) and South Amer-
ica (9.9%) have intermediate prevalences. The prevalence
given for Western Europe (including Portugal) is 5.9%,
lower that the data from the Matosinhos study. These
studies have gathered data from different sources and
present a rather different range of values.
The most recent publications suggest that asthma pre-
valence ranges from 7.2% to 12.2%. In the U.S. National
Surveillance for Asthma study published in 2007 the
overall prevalence of asthma was 7.2% [42]. A Germany
study from 2005 by Stock et al [43] shows a total preva-
l e n c eo fa s t h m ao f6 . 3 4 %i nt h es t u d yp o p u l a t i o n .A
study from South Australia from 2006 by Wilson et al
[44] shows that asthma prevalence increased from 7.5%
to 12.2% from 1990 to 2003. In a Swedish study from
2009 by Lötvall et al [45], asthma prevalence, defined as
asthma diagnosed by a physician, was 8.3%. In a Norwe-
gian study from 2003 by Brogger et al [46], the crude
prevalence of ever having had a doctor’sd i a g n o s i so f
asthma increased from 3.4 to 9.3% from 1972 to 1998-
99. Table 5 presents a comparison of published interna-
tional asthma prevalence rates.
Comparison of prevalence by age groups
In the United States National Surveillance for Asthma,
the prevalence rate among the birth to 4 year age group
was 5.9% [42]. A study among kindergartners in Chicago
public schools (mean age 5.7 yrs) found a prevalence of
asthma of 10.8% [47]. Data published by The Los
Angeles County Health Survey [48] shows a prevalence
of asthma in the birth to 5 years group of 5.9%.
Martinez et al. [49] studied wheezing before the age of
three years and the relation to wheezing at six years of
age and found that at the age of six years 13.7% of the
studied children had wheezing both before three and at
six years of age. Children with persistent wheezing had
significantly reduced lung function. According to data
from the New York State Asthma Surveillance, children
from birth to 4 years in New York State had an asthma
prevalence of 7.5% in 2006-2008 [50]. In a study carried
out in Asturias, Spain, asthma prevalence calculated for
infants was 7.6% [51]. In the Matosinhos survey, asthma
prevalence in the birth to 7 years age group was 9.59%,
close to figures found in published data.
In the study from 2008 by Ramos et al [32] in a sample
of 13 year old urban adolescents the lifetime prevalence of
asthma was 12.9%, with 84.4% of the diagnoses confirmed
by a physician. In the Matosinhos survey, the prevalence
in the age group 8 to 19 years was 13.13%. In the study by
Nunes [24] the prevalence for a similar age group (7 to 17
years) was 3.4%. Vicente et al [28] found a prevalence of
3.2% in those aged 12 to 19 years old. In the age group 20
to 64 years, our study showed a prevalence of 12.86%
while other Portuguese surveys found a prevalence of 3.1%
and 4.3% [23,39]. There were no Portuguese data found
for comparison of either the lower age groups (0 to 7
years) or for the elderly (over 65 years).
A Swedish study from 2006 [52] in children aged 7 to
8 years reported an increase in prevalence from 1996 to
2006 from 5.7% to 7.4%. In New Zealand the prevalence
of asthma is considerably higher. In the ISAAC Phase
Three study by Asher et al [53] repeating the question-
naire survey of two age groups of school children (6 to7
years and 13 to 14 years), the prevalence rates found
Table 4 Comparison of asthma prevalence rates for all age groups and methods in Portuguese surveys
Year Study Prevalence % Method
1992 Nunes et al [26] 5.5 Questionnaire
2005 Branco et al [31] 8.6 Self-report/Interview
2006 Portuguese National Health Survey [40] 5.5 Self-report/Interview
2009 Correia-de-Sousa et al 10.2 Questionnaire, self-report of symptoms
Table 5 International comparison of asthma prevalence
rates for all age groups
Year Study Country Prevalence
%
2003 Brogger et al [46] Norway 9.3
2005 Stcok et al [43] Germany 6.34
2006 Wilson et al [44] Australia 12.2
2007 National Surveillance for Asthma US
[42]
USA 7.2
2009 Lötvall et al [45] Sweden 8.3
2009 Correia-de-Sousa et al Portugal 10.2
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III of the International Study of Asthma and Allergies in
Childhood (ISAAC) [12] in the age groups 6 to7 years
and 13 to 14 years provide data for international com-
parison of prevalence rates for asthma and wheezing.
The Portuguese data from this study show a mean life-
time prevalence of asthma in the age group 6 to7 years
of 9.8% and 13.2% for the 13 to 14 year age group.
These results are similar to our findings. The U.S.
National Surveillance for Asthma study [42] found the
prevalence to be 8.5% among those under 18 years and
6-7% for those over 18.
The U.S. National Health and Nutrition Examination
S u r v e y( N H A N E SI I I )[ 5 4 ]f o u n da na s t h m ap r e v a l e n c e
on the age group over 20 years of 4.5%. In the Danish
survey by Browatzki et al [55] published in 2009, the
prevalence of self-reported asthma in the age group 20
to 35 years was 6.9%.
In the U.S. National Surveillance for Asthma study
[42] the lifetime prevalence of asthma in individuals
over 65 years of age was found to be 6.8%, though the
percentage of elderly patients with “current” asthma was
5.9%. In the NHANHES III survey [54], the prevalence
over 60 years was 3.6%. In our study, the prevalence for
the over 65 age group was 5%.
The comparison of the findings of the current study
with other studies computing lifetime prevalence of
asthma is relevant because the current study included
questions assessing if the patent had ever been told they
had asthma.
Comparison of asthma prevalence by gender
Some studies report a clear gender difference [52,56],
considering male gender to be associated with the
increased risk of asthma in children. Prior to the age of
1 4 ,t h ep r e v a l e n c eo fa s t h m am a yb en e a r l yt w i c ea s
great in boys as in girls [2].
In the present study there was no statistically significant
difference in the prevalence of asthma by gender, though,
among young children under the age of 8 years the preva-
lence of asthma is higher in males (13%) than in females
(7%) but this was not statistically significant. Branco et al
[31] also found no significant gender differences in asthma
prevalence. This study was most similar to the Matosinhos
survey. In some Portuguese surveys the overall prevalence
for females is higher than for males [39,40], while in other
the reverse was observed [32].
The U.S. National Surveillance for Asthma study [42]
shows a difference in prevalence by genders with 8.1%
among females and 6.2% among males. The report from
the ISAAC phase I and III studies in Spain [56] shows a
difference in prevalence by gender. In the age group 6
to 7 years, girls had 9.0% and boys 12.9%. In the age
group 13 to 14 years, girls had 11.8% and boys 13.8%.
T h eD a n i s hs t u d yo ft h ep r e v a l e n c ea n ds e v e r i t yo f
asthma in young Danish adults over three decades
shows a higher female prevalence in all the three phases.
The female to male ratio was 1.7/1.2 in 1978, 4.8/4.5 in
1994 and 7.7/5.9 in 2004 [55].
Discussion of methods
Using the best knowledge about asthma from both the
patient and the physician was also used in a Swedish
study published in 2005. The authors concluded that a
combination of a medically verified asthma diagnosis
using medical records and the use of self-reported
symptoms with the ISAAC questionnaire seem to be
valid and reliable for the follow-up childhood asthma in
the community [57]. This is the method we chose for
diagnosis in our study and it seems to be a feasible
method for increasing diagnostic accuracy. It may
explain the higher prevalence found in our study com-
pared to other Portuguese studies.
Implications
The findings of the current study suggest that asthma
might have been under-reported in other epidemiologi-
cal studies in Portugal. This may also be true in other
countries. The use of accepted diagnostic criteria using
the best knowledge from both the doctor and the
patient may help to overcome this.
Careful assessment of symptoms can lead to more
accurate diagnosis of population. Skilful application of
this method in clinical practice may help to identify those
patients who may benefit from appropriate treatment.
Conclusions
Use of the best knowledge about asthma from both the
patient and the physician seems to be a good strategy
for the determination of the prevalence of asthma in a
community survey.
T h ep r e v a l e n c eo fa s t h m af o u n di nt h ep r e s e n ts t u d y
was higher than that found in some studies, though
other studies have found a prevalence above 10%.
T h ep r e v a l e n c eo fa s t h m ai nt h eb i r t ht o7a g eg r o u p
was lower than expected due to diagnostic problems.
Based on these data, assuming a prevalence of asthma
of 10%, with the current population of Portugal of
10,893,010 in 2011, we may expect 1,089,301 persons to
have asthma in Portugal.
Further studies in other regions of Portugal using the
same diagnostic criteria and sampling methods should
be done in order to confirm these findings.
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